173 related articles for article (PubMed ID: 25510600)
1. Targeted killing of cancer cells in vivo and in vitro with IGF-IR antibody-directed carbon nanohorns based drug delivery.
Li N; Zhao Q; Shu C; Ma X; Li R; Shen H; Zhong W
Int J Pharm; 2015 Jan; 478(2):644-54. PubMed ID: 25510600
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional nanoassemblies for vincristine sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated efflux.
Zhang P; Ling G; Sun J; Zhang T; Yuan Y; Sun Y; Wang Z; He Z
Biomaterials; 2011 Aug; 32(23):5524-33. PubMed ID: 21546082
[TBL] [Abstract][Full Text] [Related]
3. Dispersion of cisplatin-loaded carbon nanohorns with a conjugate comprised of an artificial peptide aptamer and polyethylene glycol.
Matsumura S; Ajima K; Yudasaka M; Iijima S; Shiba K
Mol Pharm; 2007; 4(5):723-9. PubMed ID: 17685580
[TBL] [Abstract][Full Text] [Related]
4. Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature.
Wang C; Zhao M; Liu YR; Luan X; Guan YY; Lu Q; Yu DH; Bai F; Chen HZ; Fang C
Biomaterials; 2014 Jan; 35(4):1215-26. PubMed ID: 24231414
[TBL] [Abstract][Full Text] [Related]
5. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
[TBL] [Abstract][Full Text] [Related]
6. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
[TBL] [Abstract][Full Text] [Related]
7. Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro.
Murakami T; Ajima K; Miyawaki J; Yudasaka M; Iijima S; Shiba K
Mol Pharm; 2004; 1(6):399-405. PubMed ID: 16028351
[TBL] [Abstract][Full Text] [Related]
8. Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.
Murakami T; Sawada H; Tamura G; Yudasaka M; Iijima S; Tsuchida K
Nanomedicine (Lond); 2008 Aug; 3(4):453-63. PubMed ID: 18694307
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanoparticles as nanocarrier for vincristine sulfate delivery to overcome tumor multidrug resistance.
Wang Y; Dou L; He H; Zhang Y; Shen Q
Mol Pharm; 2014 Mar; 11(3):885-94. PubMed ID: 24483832
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of doxorubicin and vincristine to lymph cancer: evaluation of novel nanostructured lipid carriers in vitro and in vivo.
Dong X; Wang W; Qu H; Han D; Zheng J; Sun G
Drug Deliv; 2016 May; 23(4):1374-8. PubMed ID: 26208133
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile.
Sui L; Yang T; Gao P; Meng A; Wang P; Wu Z; Wang J
Int J Pharm; 2014 Aug; 471(1-2):157-65. PubMed ID: 24853461
[TBL] [Abstract][Full Text] [Related]
12. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
[TBL] [Abstract][Full Text] [Related]
13. Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery.
Chen J; Li S; Shen Q
Eur J Pharm Sci; 2012 Sep; 47(2):430-43. PubMed ID: 22796217
[TBL] [Abstract][Full Text] [Related]
14. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system.
Qiu L; Dong C; Kan X
Drug Des Devel Ther; 2018; 12():863-872. PubMed ID: 29713144
[TBL] [Abstract][Full Text] [Related]
16. Solubilization of single-wall carbon nanohorns using a PEG-doxorubicin conjugate.
Murakami T; Fan J; Yudasaka M; Iijima S; Shiba K
Mol Pharm; 2006; 3(4):407-14. PubMed ID: 16889434
[TBL] [Abstract][Full Text] [Related]
17. [VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma].
He YJ; Lin TT; Zhu LM; Luo H; Chang J; Zhang H; Zhang HM
Zhonghua Yan Ke Za Zhi; 2010 Sep; 46(9):795-801. PubMed ID: 21092558
[TBL] [Abstract][Full Text] [Related]
18. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD133 Antibody-Targeted Therapeutic Immunomagnetic Albumin Microbeads Loaded with Vincristine-Assisted to Enhance Anti-Glioblastoma Treatment.
Wang X; Lu P; Zhu L; Qin L; Zhu Y; Yan G; Duan S; Guo Y
Mol Pharm; 2019 Nov; 16(11):4582-4593. PubMed ID: 31573817
[TBL] [Abstract][Full Text] [Related]
20. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.
Su Z; Shi Y; Xiao Y; Sun M; Ping Q; Zong L; Li S; Niu J; Huang A; You W; Chen Y; Chen X; Fei J; Tian J
Int J Pharm; 2013 Apr; 447(1-2):281-92. PubMed ID: 23396258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
